Poster Session E - Tuesday Afternoon
Category: Small Intestine
Anna H. Lee, MD
University of California, Los Angeles
Los Angeles, CA
GAD | GAD + Overlap IBS | p-value | ||
Demographics | ||||
Female gender1 | 90.5% | 90.0% | 1 | |
Age | 57.0 (51.0-63.0) | 44.0 (36.0-51.2) | 0.128 | |
GAD Diagnosis1 | ||||
Celiac Disease | 81.0% | 60.0% | --2 | |
Dermatitis Herpetiformis +/- Celiac Disease | 19.0% | 30.0% | ||
Non-Celiac Gluten Sensitivity/Wheat Sensitivity | 0.0% | 10.0% | ||
GAD Disease Duration | ||||
8.0 (2.0-12.0) | 4.5 (1.0-10.0) | 0.317 | ||
IBS Symptom Severity (IBS-SSS) | ||||
-- | 344.5 (323.8-377.2) | -- | ||
IBS-SSS Categories1 | ||||
Mild | -- | 0.0% | -- | |
Moderate | -- | 16.7% | ||
Severe | -- | 83.3% | ||
GFD Adherence (CDAT) | ||||
12.5 (10.8-15.2) | 13.0 (9.0-14.0) | 0.905 | ||
Celiac Disease Activity (CSI) | ||||
35.5 (31.8-37.2) | 39.0 (35.0-43.0) | 0.106 | ||
Relationship with Healthcare Provider (HCCQ) | ||||
19.0 (10.5-36.5) | 39.0 (28.0-42.0) | 0.013 |